US health reform makes progress, along with $4bn “sucker-punch” tax on medtech
This article was originally published in Clinica
Executive Summary
The US medtech industry has given an understandably mixed response to the Senate finance committee’s approval on October 13 of a package of measures that will radically transform the American healthcare system. The sore point for industry is that a $4bn annual medtech tax remains in the reform proposal.